PHYH
protein-codingphytanoyl-CoA 2-hydroxylase
Gene summary
This gene is a member of the PhyH family and encodes a peroxisomal protein that is involved in the alpha-oxidation of 3-methyl branched fatty acids. Specifically, this protein converts phytanoyl-CoA to 2-hydroxyphytanoyl-CoA. Mutations in this gene have been associated with Refsum disease (RD) and deficient protein activity has been associated with Zellweger syndrome and rhizomelic chondrodysplasia punctata. Alternate transcriptional splice variants, encoding different isoforms, have been characterized. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~24.6 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0009958
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0009958
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0009958
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0100258
Submitter: ClinGen
*PHYH* was first reported in relation to autosomal recessive phytanoyl-CoA hydroxylase deficiency (adult Refsum disease included) in 1997 (Jansen et al., PMID: 9326940). Numerous variants have been reported in humans per ClinVar. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Summary of case-level and experimental data: 14.5 points. Variants in this gene have been reported in at least 16 probands in 4 publications (PMIDS: 25604618, 31240149, 17905308,10767344, 9326940, 22156782, 9326939, 28681609). This gene-disease association is supported by animal models and in vitro functional assays. In summary, *PHYH* is definitively associated with autosomal recessive phytanoyl-CoA hydroxylase deficiency. This has been repeatedly demonstrated in both the research and clinical diagnostic settings and has been upheld over time.
Inheritance Pattern: AR
Disease ID:MONDO:0009958
Submitter: Laboratory for Molecular Medicine
This gene-disease relationship has undergone rapid assessment. Classifications are based on preliminary review of gene-disease validity during analysis of genomic sequencing results.
Inheritance Pattern: AR
Disease ID:MONDO:0009958
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0009958
Submitter: Orphanet
Clinical Genomic Database (CGD)
Manifestation: Audiologic/Otolaryngologic; Biochemical; Cardiovascular; Dermatologic; Musculoskeletal; Neurologic; Ophthalmologic
Intervention: Biochemical; Cardiovascular; Pharmacogenomic
Rationale: Dietary measures (high calorie diet with phytanic acid restriction) may be beneficial; Surveillance can allow early diagnosis and treatment of cardiac manifestsations (eg, cardiac arrhythmias, cardiomyopathy); Plasmapheresis/lipid apheresis may be indicated in severe situations; Certain agents/circumstances (eg, fasting, ibuprofen) should be avoided
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to PHYH variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_006214.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 6 | 117 | 123 | |||
| missense | 3 | 9 | 166 | 11 | 1 | 190 |
| nonsense | 11 | 11 | 2 | 24 | ||
| start loss | 3 | 1 | 4 | |||
| frameshift | 33 | 19 | 52 | |||
| splice donor/acceptor (+/-2bp) | 1 | 20 | 3 | 24 | ||
| Total | 48 | 62 | 178 | 128 | 1 | 417 |
Highest pathogenic variant AF is 0.00016865932
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_006205.1 | 9 | MANE Select | |
| Ensembl | ENSP00000263038.4 | 9 | MANE Select | |
| RefSeq | NP_001032626.1 | 6 | Standard | |
| RefSeq | NP_001310009.1 | 6 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Peroxisome - Homo sapiens (human)
- Oxidation of Branched Chain Fatty Acids
- Refsum Disease
- Phytanic Acid Peroxisomal Oxidation
- Metabolism of lipids
Biological Process
- fatty acid alpha-oxidation
- 2-oxoglutarate metabolic process
- protein targeting to peroxisome
- isoprenoid metabolic process
- methyl-branched fatty acid metabolic process
Molecular Function
- protein binding
- ferrous iron binding
- carboxylic acid binding
- L-ascorbic acid binding
- cofactor binding
Cellular Component
- peroxisome
- peroxisomal matrix
- cytosol
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000263038
- Coding exons
- 9
- Length
- 24617
- Individuals with no LoFs
- 125689
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 59
- Defined
- 125748
- p
- 0.000235
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.0310 | 194 | 195 | 0.994 | 0.0000113 | 2245 |
| Missense (PolyPhen) | 53 | 53.778 | 0.98554 | 597 | ||
| Synonymous | 0.292 | 72 | 75.2 | 0.957 | 0.00000522 | 619 |
| Loss of Function | 1.20 | 11 | 16.2 | 0.678 | 6.96e-7 | 200 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00012 | 0.00012 | rare |
| Latino/Admixed American | 0.00017 | 0.00017 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00016 | 0.00016 | rare |
| Finnish | 0.00046 | 0.00046 | rare |
| European (Non-Finnish) | 0.00032 | 0.00032 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0.00016 | 0.00016 | rare |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Converts phytanoyl-CoA to 2-hydroxyphytanoyl-CoA.;
Recessive Scores
- pRec
- 0.229
Intolerance Scores
- LoFtool
- 0.119
- RVIS EVS
- 0.62
- RVIS percentile EVS
- 83.36
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.670
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |